Neostigmine Methyl Sulfate (CAS Number: 51-60-5) is a reversible anticholinesterase (acetylcholinesterase inhibitor) widely used in veterinary medicine. Manufactured according to in-house quality standards, it plays an important role in the management of neuromuscular disorders, anesthesia recovery, and gastrointestinal motility conditions in animals.

By inhibiting the breakdown of acetylcholine, Neostigmine Methyl Sulfate enhances nerve-to-muscle signal transmission and smooth muscle activity, supporting functional recovery in multiple physiological systems.

Product Overview

 

• Product Name: Neostigmine Methyl Sulfate (Veterinary Use)
• CAS Number: 51-60-5
• Standard: In-house
• Drug Class: Reversible acetylcholinesterase inhibitor
• Primary Action: Enhances neuromuscular transmission

Mechanism of Action

 

 

 

Neostigmine Methyl Sulfate works by inhibiting acetylcholinesterase, the enzyme responsible for degrading acetylcholine. Increased acetylcholine levels at the neuromuscular junction and smooth muscle synapses lead to:

 

• Improved skeletal muscle contraction
• Enhanced nerve signal transmission
• Increased smooth muscle activity in the gastrointestinal tract

Applications in Veterinary Medicine

 

1. Management of Myasthenia Gravis in Animals

 

Neostigmine Methyl Sulfate is most commonly used to manage myasthenia gravis, a rare autoimmune neuromuscular disorder that causes muscle weakness and fatigue in animals.

 

Therapeutic benefits include:

• Improved muscle strength
• Reduced fatigue
• Enhanced mobility and quality of life

By promoting acetylcholine accumulation at synapses, it restores effective neuromuscular transmission.

2. Neuro-Muscular Support and Recovery

 

Preclinical and veterinary studies suggest that Neostigmine Methyl Sulfate may support nerve and muscle recovery following injury by:

 

• Improving neuromuscular signaling
• Supporting functional regeneration
• Reducing secondary neuromuscular impairment

 

These effects make it valuable in veterinary neurological and rehabilitation settings.

 

3. Gastrointestinal Motility Enhancement

Neostigmine Methyl Sulfate is used to treat gastrointestinal motility disorders in animals, including:

• Postoperative ileus
• Intestinal hypomotility
• Severe constipation

 

By stimulating parasympathetic nerve activity, it enhances intestinal smooth muscle contraction and helps restore normal bowel function.

 

4. Reversal of Neuromuscular Blockade (Anesthesia Recovery)

 

In veterinary surgery, Neostigmine Methyl Sulfate is commonly administered to reverse neuromuscular blocking agents used during anesthesia. It helps:

 

• Restore spontaneous breathing
• Recover voluntary muscle movement
• Reduce anesthesia recovery time

 

This application is critical for safe postoperative care in animals.

Conclusion

 

 

Neostigmine Methyl Sulfate (CAS No. 51-60-5) is a multifunctional and well-established veterinary medication with proven efficacy in:

 

• Treating myasthenia gravis in animals
• Supporting neuromuscular recovery
• Enhancing gastrointestinal motility
• Reversing anesthesia-induced muscle paralysis

 

Its reliable mechanism of action and broad clinical utility make it an essential drug in modern veterinary medicine.